Combined Male tumour markers

Alpha fetoprotein (AFP) is used to screen for and monitor therapy for certain cancers of the liver and testes. In the presence of certain cancers, including bowel cancer, Carcino Embryonic Antigen (CEA) may be used to monitor the effect of treatment and recurrence of disease. CA 199 is a test to help tell the difference between cancer of the pancreas and bile ducts and other conditions; and to monitor response to pancreatic cancer treatment and to watch for recurrence. A PSA blood test helps detect and to monitor prostate cancer. It may be useful if you have symptoms of prostate disease, such as poor flow difficulty in passing urine, straining or taking long time while urinating, hesitancy, weak flow, terminal dribbling (not able to stop the flow at the end of urination) or passing urine more frequently than usual especially during the night.